Inbred SJL mice recapitulate human resistance to Cryptococcus infection due to differential immune activation
ABSTRACT Cryptococcosis remains a significant threat to human health. While the popular C57BL/6J mouse model of cryptococcosis has some advantages, there are some serious shortcomings that limit the ability of researchers to address the disease. Since humans are resistant to environmental cryptococc...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Society for Microbiology
2023-10-01
|
| Series: | mBio |
| Subjects: | |
| Online Access: | https://journals.asm.org/doi/10.1128/mbio.02123-23 |
| _version_ | 1797619673481609216 |
|---|---|
| author | M. J. Davis R. E. Martin G. M. Pinheiro E. S. Hoke S. Moyer K. Ueno J. L. Rodriguez-Gil M. A. Mallett J. S. Khillan W. J. Pavan Y. C. Chang K. J. Kwon-Chung |
| author_facet | M. J. Davis R. E. Martin G. M. Pinheiro E. S. Hoke S. Moyer K. Ueno J. L. Rodriguez-Gil M. A. Mallett J. S. Khillan W. J. Pavan Y. C. Chang K. J. Kwon-Chung |
| author_sort | M. J. Davis |
| collection | DOAJ |
| description | ABSTRACT Cryptococcosis remains a significant threat to human health. While the popular C57BL/6J mouse model of cryptococcosis has some advantages, there are some serious shortcomings that limit the ability of researchers to address the disease. Since humans are resistant to environmental cryptococcal infection until rendered immunodeficient while C57BL/6J mice are innately susceptible, we screened 15 inbred mouse strains for resistance to Cryptococcus infection. The SJL/J mouse strain was unusually resistant to several virulent strains of Cryptococcus while the closely related FVB/J strain was susceptible. The infection pathobiology in SJL/J mice and susceptible mice was similar for the first 7–10 days then markedly diverged toward pathogen clearance. Interferon-gamma (IFN-γ) expression was critical for SJL/J resistance while tumor necrosis factor-alpha was also important. Both CD4 and CD8 T cells produced IFN-γ and were collectively critical. While IL-17 and associated cytokines were expressed in SJL/J mice, IL-17 inhibition did not affect the outcome of infection. Unlike the C57BL/6J, infected SJL/J mice failed to express Th2/atopy-type cytokines even when rendered susceptible by IFN-γ blockade or infection with an alternative fatal cryptococcal strain virulent in SJL/J. These data suggest that the atopic-type response typically associated with the C57BL/6J model is not critical for susceptibility. The productive immune response in SJL/J mice resulted in immune memory that protected mice from reinfection. The SJL/J cryptococcal resistance phenotype was associated with a strong genetic linkage from regions located in chromosomes 2 and 11 suggesting strain-specific modifiers contribute to disease severity. Thus, SJL/J mice are an exciting alternative animal model for cryptococcal pathobiology. IMPORTANCE Cryptococcosis studies often utilize the common C57BL/6J mouse model. Unfortunately, infection in these mice fails to replicate the basic course of human disease, particularly hampering immunological studies. This work demonstrates that SJL/J mice can recapitulate human infection better than other mouse strains. The immunological response to Cryptococcus infection in SJL/J mice was markedly different from C57BL/6J and much more productive in combating this infection. Characterization of infected mice demonstrated strain-specific genetic linkage and differential regulation of multiple important immune-relevant genes in response to Cryptococcus infection. While our results validate many of the previously identified immunological features of cryptococcosis, we also demonstrate limitations from previous mouse models as they may be less translatable to human disease. We concluded that SJL/J mice more faithfully recapitulate human cryptococcosis serving as an exciting new animal model for immunological and genetic studies. |
| first_indexed | 2024-03-11T08:30:06Z |
| format | Article |
| id | doaj.art-1e8e033c4a354621aab6186093ecdc90 |
| institution | Directory Open Access Journal |
| issn | 2150-7511 |
| language | English |
| last_indexed | 2024-03-11T08:30:06Z |
| publishDate | 2023-10-01 |
| publisher | American Society for Microbiology |
| record_format | Article |
| series | mBio |
| spelling | doaj.art-1e8e033c4a354621aab6186093ecdc902023-11-16T21:48:01ZengAmerican Society for MicrobiologymBio2150-75112023-10-0114510.1128/mbio.02123-23Inbred SJL mice recapitulate human resistance to Cryptococcus infection due to differential immune activationM. J. Davis0R. E. Martin1G. M. Pinheiro2E. S. Hoke3S. Moyer4K. Ueno5J. L. Rodriguez-Gil6M. A. Mallett7J. S. Khillan8W. J. Pavan9Y. C. Chang10K. J. Kwon-Chung11Molecular Microbiology Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) , Bethesda, Maryland, USAMolecular Microbiology Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) , Bethesda, Maryland, USAMolecular Microbiology Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) , Bethesda, Maryland, USAMolecular Microbiology Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) , Bethesda, Maryland, USAMolecular Microbiology Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) , Bethesda, Maryland, USAMolecular Microbiology Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) , Bethesda, Maryland, USAGenomics, Development and Disease Section, Computational and Statistical Genomics Branch, National Human Genome Research Institute, National Institutes of Health (NIH) , Bethesda, Maryland, USAMouse Genetics and Gene Modification Section, Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) , Bethesda, Maryland, USAMouse Genetics and Gene Modification Section, Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) , Bethesda, Maryland, USAGenomics, Development and Disease Section, Computational and Statistical Genomics Branch, National Human Genome Research Institute, National Institutes of Health (NIH) , Bethesda, Maryland, USAMolecular Microbiology Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) , Bethesda, Maryland, USAMolecular Microbiology Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) , Bethesda, Maryland, USAABSTRACT Cryptococcosis remains a significant threat to human health. While the popular C57BL/6J mouse model of cryptococcosis has some advantages, there are some serious shortcomings that limit the ability of researchers to address the disease. Since humans are resistant to environmental cryptococcal infection until rendered immunodeficient while C57BL/6J mice are innately susceptible, we screened 15 inbred mouse strains for resistance to Cryptococcus infection. The SJL/J mouse strain was unusually resistant to several virulent strains of Cryptococcus while the closely related FVB/J strain was susceptible. The infection pathobiology in SJL/J mice and susceptible mice was similar for the first 7–10 days then markedly diverged toward pathogen clearance. Interferon-gamma (IFN-γ) expression was critical for SJL/J resistance while tumor necrosis factor-alpha was also important. Both CD4 and CD8 T cells produced IFN-γ and were collectively critical. While IL-17 and associated cytokines were expressed in SJL/J mice, IL-17 inhibition did not affect the outcome of infection. Unlike the C57BL/6J, infected SJL/J mice failed to express Th2/atopy-type cytokines even when rendered susceptible by IFN-γ blockade or infection with an alternative fatal cryptococcal strain virulent in SJL/J. These data suggest that the atopic-type response typically associated with the C57BL/6J model is not critical for susceptibility. The productive immune response in SJL/J mice resulted in immune memory that protected mice from reinfection. The SJL/J cryptococcal resistance phenotype was associated with a strong genetic linkage from regions located in chromosomes 2 and 11 suggesting strain-specific modifiers contribute to disease severity. Thus, SJL/J mice are an exciting alternative animal model for cryptococcal pathobiology. IMPORTANCE Cryptococcosis studies often utilize the common C57BL/6J mouse model. Unfortunately, infection in these mice fails to replicate the basic course of human disease, particularly hampering immunological studies. This work demonstrates that SJL/J mice can recapitulate human infection better than other mouse strains. The immunological response to Cryptococcus infection in SJL/J mice was markedly different from C57BL/6J and much more productive in combating this infection. Characterization of infected mice demonstrated strain-specific genetic linkage and differential regulation of multiple important immune-relevant genes in response to Cryptococcus infection. While our results validate many of the previously identified immunological features of cryptococcosis, we also demonstrate limitations from previous mouse models as they may be less translatable to human disease. We concluded that SJL/J mice more faithfully recapitulate human cryptococcosis serving as an exciting new animal model for immunological and genetic studies.https://journals.asm.org/doi/10.1128/mbio.02123-23complementCryptococcus neoformansTh1/Th2atopic immunityQTL analysis |
| spellingShingle | M. J. Davis R. E. Martin G. M. Pinheiro E. S. Hoke S. Moyer K. Ueno J. L. Rodriguez-Gil M. A. Mallett J. S. Khillan W. J. Pavan Y. C. Chang K. J. Kwon-Chung Inbred SJL mice recapitulate human resistance to Cryptococcus infection due to differential immune activation mBio complement Cryptococcus neoformans Th1/Th2 atopic immunity QTL analysis |
| title | Inbred SJL mice recapitulate human resistance to Cryptococcus infection due to differential immune activation |
| title_full | Inbred SJL mice recapitulate human resistance to Cryptococcus infection due to differential immune activation |
| title_fullStr | Inbred SJL mice recapitulate human resistance to Cryptococcus infection due to differential immune activation |
| title_full_unstemmed | Inbred SJL mice recapitulate human resistance to Cryptococcus infection due to differential immune activation |
| title_short | Inbred SJL mice recapitulate human resistance to Cryptococcus infection due to differential immune activation |
| title_sort | inbred sjl mice recapitulate human resistance to cryptococcus infection due to differential immune activation |
| topic | complement Cryptococcus neoformans Th1/Th2 atopic immunity QTL analysis |
| url | https://journals.asm.org/doi/10.1128/mbio.02123-23 |
| work_keys_str_mv | AT mjdavis inbredsjlmicerecapitulatehumanresistancetocryptococcusinfectionduetodifferentialimmuneactivation AT remartin inbredsjlmicerecapitulatehumanresistancetocryptococcusinfectionduetodifferentialimmuneactivation AT gmpinheiro inbredsjlmicerecapitulatehumanresistancetocryptococcusinfectionduetodifferentialimmuneactivation AT eshoke inbredsjlmicerecapitulatehumanresistancetocryptococcusinfectionduetodifferentialimmuneactivation AT smoyer inbredsjlmicerecapitulatehumanresistancetocryptococcusinfectionduetodifferentialimmuneactivation AT kueno inbredsjlmicerecapitulatehumanresistancetocryptococcusinfectionduetodifferentialimmuneactivation AT jlrodriguezgil inbredsjlmicerecapitulatehumanresistancetocryptococcusinfectionduetodifferentialimmuneactivation AT mamallett inbredsjlmicerecapitulatehumanresistancetocryptococcusinfectionduetodifferentialimmuneactivation AT jskhillan inbredsjlmicerecapitulatehumanresistancetocryptococcusinfectionduetodifferentialimmuneactivation AT wjpavan inbredsjlmicerecapitulatehumanresistancetocryptococcusinfectionduetodifferentialimmuneactivation AT ycchang inbredsjlmicerecapitulatehumanresistancetocryptococcusinfectionduetodifferentialimmuneactivation AT kjkwonchung inbredsjlmicerecapitulatehumanresistancetocryptococcusinfectionduetodifferentialimmuneactivation |